The Muscle Relaxant Drugs Global Market Report 2023 by The Business Research Company, provides muscle relaxant drugs market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.
Learn More On The Muscle Relaxant Drugs Market:
https://www.thebusinessresearchcompany.com/report/muscle-relaxant-drugs-global-market-report
According to The Business Research Company’s Muscle Relaxant Drugs Global Market Report 2023, the market size is expected to grow from $4.13 billion in 2022 to $4.45 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global muscle relaxant drugs market is expected to reach $5.79 billion in 2027 at a CAGR of 6.8%.
The rising geriatric population is expected to propel the growth of the muscle relaxant drugs market going forward. The geriatric population refers to older adults 65 years and beyond. Muscle relaxant drugs are used for sedating and reducing the pain of the geriatric population who are more likely to suffer from musculoskeletal disorders
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=8751&type=smp
The muscle relaxant drugs market is segmented:
1) By Drug Type: Facial Muscle Relaxant Drugs, Skeletal Muscle Relaxant Drugs, Neuromuscular Blocking Agents
2) By Route of Administration: Oral, Injectable, Spray, Ointment
3) By Formulation: Cyclobenzaprine, Carisoprodol, Chlorzoxazone, Metaxalone, Methocarbamol, Baclofen, Tizanidine, Orphenadrine, Dantrolene
4) By End-User: Hospitals, Homecare, Speciality Clinics, Other End-Users
Product innovations are the key trend gaining popularity in the muscle relaxant drugs market going forward. Major companies operating in the market are developing innovative drugs for specific medical applications such as generic versions of muscle relaxant drugs, muscle relaxants for animals, drugs that provide flexible, customized dosing, and others to sustain their position in the market. For instance, in June 2022, Amneal Pharmaceuticals Inc., a US-based integrated specialty pharmaceutical company, launched LYVISPAH®, a baclofen oral granule (5, 10, and 20 mg) specialty product approved by the US Food and Drug Administration for the treatment of spasticity associated with multiple sclerosis and other spinal cord disorders. LYVISPAHi offers flexible, customized dosing with 5mg, 10mg, and 20mg single-dose packets of granules that are used in treating muscle stiffness, spasms, and pain from multiple sclerosis. The rapidly dissolving flavored granules offer an alternative for patients with spasticity who also have difficulty swallowing pills. The product can be administered in three ways: directly into the patient’s mouth with or without water, mixed with liquids or foods, or through an enteral feeding tube.
The muscle relaxant drugs market report table of contents includes:
1. Executive Summary
2. Muscle Relaxant Drugs Market Characteristics
3. Muscle Relaxant Drugs Market Trends And Strategies
4. Muscle Relaxant Drugs Market – Macro Economic Scenario
5. Muscle Relaxant Drugs Market Size And Growth
.
.
.
26. Africa Muscle Relaxant Drugs Market
27. Muscle Relaxant Drugs Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Muscle Relaxant Drugs Market
29. Muscle Relaxant Drugs Market Future Outlook and Potential Analysis
30. Appendix
Top Major Players:
- Pfizer Inc
- Ipsen Pharma
- Teijin Limited
- Par Pharmaceutical
- Orient Pharma
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
